Jump to content
RemedySpot.com

[CoMeD] DrftRevu of Mercury Metabolism in Lab Rats

Rate this topic


Recommended Posts

Posted

ALL,

Attached are the " doc " and " pdf " files for a review of

the revcent paper that shed additional light on the

distribution and metabolism of Thimerosal's mercury in

lab rats.

For those who do not receive attachments, the " .pdf "

version of this article can be found in bothe the

" Documents " section of the CoMeD web site:

http://www.Mercury-freeDrugs.org

as well as in thethe " 2010 " sub-section of the

" Documents " web page on : http://www.dr-king.com by

the end of December 2010 at the latest.

In addition, the rough text of the article (without

the footnotes and the table is as follows:

>

>

>Thimerosal: Mercury metabolism and distribution in

>laboratory rats?

>

>The most recent rat study (JL Rodriques et al. 2010

>[Rodriques]), which compared the dosing of mercury

>from Thimerosal to the mercury from " methylmercury " ,

>used a more self-consistent " dosing " design than the

>2005 study (TM Burbacher et al. 2005 [burbacher]) in

>infant monkeys.

>

>Unlike the 2005 Burbacher study, which injected the

>Thimerosal and gavaged (force-fed) the " methylmercury "

>compound studied, the 2010 Rodriques study force-fed

>solutions of both.

>

>In addition, the Rodriques study more exactly determined

>the nature of the types of mercury compounds in the blood

>and tissue samples assessed than the Burbacher study did.

>

>However, like the cited Burbacher study in infant monkeys,

>the 2010 Rodriques study suffers from some significant

>design and reporting weaknesses including, but not

>limited to:

> 1. This study inappropriately doses the mercury compounds

> by force-feeding them rather than, as it should, if it

> truly were a study interested in studying the compara-

> tive toxicokinetics of mercury compounds, injecting

> them into the rats subcutaneously.

> 2. Similar to an unsupported declaration made in the

> Burbacher study, the Rodriques study makes an

> unsubstantiated claim: " Our studies demonstrate that

> mercury derived from TM " [the abbreviation used for

> Thimerosal] " is cleared from the rats more quickly

> than Met-Hg " .

> 3. Like Burbacher, the " methylmercury " compound chosen,

> methylmercury chloride in the current Rodriques study

> (as compared to methylmercury hydroxide in Burbacher

> et al. 2005), was the wrong compound upon which to

> base truly comparative toxicological distribution

> evaluations.

> 4. The purity of the Thimerosal used was not disclosed,

> and no data was presented that verified that the

> Thimerosal solutions used had the nominal level of

> " Thimerosal " -related mercury (Hg) in them just before

> the rats were dosed with said " Thimerosal " solutions.

>

>In addition, this study failed to monitor the blood Hg

>levels at:

> ¨ 30 minutes after administration and

> ¨ 1 hour after administration.

>

>Based on the researchers' findings: " … were rapidly absorbed "

>and " just 6 h after administration, mercury is found mainly

>as inorganic mercury in TM-exposed animals " , these earlier

>sampling times are clearly required for studies that force-

>feed or inject water-based solutions of Thimerosal .

>

>Thus, there are no baseline levels and no levels near the

>time of administration of the compounds to assess the peak

>level, and the initial absorption and distribution of the

>Hg into the rats' blood from the basis Hg-containing

>solutions administered.

>

>Lacking data to verify the initial levels of " Thimerosal " Hg

>and the initial uptake of the two different Hg components

>(the complex Thimerosal-based mixture and the single-

>component methylmercury chloride solution), the blood levels

>in the Rodriques study's " Fig. 1 " only show that, besides an

>apparent kinetics-related offset, the migration of the Hg

>species from the blood into the rats' tissues seems to be

> " similar " even though the analysis-result patterns for the

>Hg-containing substances quantified clearly differ.

>

>The declaration, " After the rats were exposed to TM or Met-Hg,

>both species were rapidly absorbed " confirms: a) the Rodriques

>researchers were either: 1) unaware of the instability of

>Thimerosal in aqueous solution or 2) chose to ignore its

>instability and B) knew their tissue-distribution data was

>biased by the delaying effects of absorption from the gut into

>the body in the test rats studied.

>

>Further, the authors report, " Moreover, just 6 h after

>administration, mercury is found mainly as inorganic mercury

>in TM-exposed animals (data not shown) " , clearly indicates a

>much faster rate of metabolism for the Hg species in the rats

>given " Thimerosal " than for the Hg species in the rats force

>fed methylmercury chloride.

>

>This finding also confirms the need in the Thimerosal-treated

>rats for initial blood sampling at much at shorter intervals.

>

>The interesting commonalities between the Burbacher and Rodriquez

>studies include:

> ¨ The similar findings for relative levels of " inorganic Hg "

> species accumulating in the brain of the two test groups

> of rats, with Rodriques finding about 2.2 times as much in

> the rats treated with Thimerosal on average as in those

> similarly treated with methyl-Hg chloride;

> ¨ The approximate (order of magnitude) levels of " inorganic "

> Hg in the brain between: a) the rats treated with a single

> 0.5 mg of Hg from " Thimerosal " dissolved in water/kg of rat

> body weight and sacrificed at 5 days post treatment (about

> 170 ng of " inorganic Hg " /g of rat brain on average) and

> B) the monkeys treated with 4 doses of 0.020 mg of

> " Thimerosal " in a vaccine [aqueous buffered saline] matrix

> or 0.08 mg of " Thimerosal " and sacrificed around 5 days (1 -

> 6 days) after the last dose of " Thimerosal " was administered

> (roughly 15 ng of " inorganic Hg " /g of brain on average at 22

> to 27 days after initial dose was administered); and

> ¨ Both groups of researchers: i) focused on the Thimerosal-

> derived Hg species as being at a lower level at the time

> points where measurements were made than the methyl-mercury-

> derived Hg species and ii) claimed " clearance " (implying that

> the Thimerosal-derived-mercury species are clearing the animal)

> based solely on the average drop in the level of mercury in

> the animal's blood.

>

>The interesting difference was the Rodriques study's finding of

> " methylmercury " in the " Thimerosal " -treated rats.

>

>This finding indicates that either:

> a. The pathway for the generation of the inorganic-Hg species

> present in the tissues proceeds through repetitive demethyla-

> tion steps (Thimerosal ==> simpler ethyl-Hg species ==>

> simpler methyl-Hg species ==> inorganic-Hg species) or

> b. Less likely, the ng/g levels of " inorganic " Hg species in

> the kidney (9,581.9 ng/g), liver (2999.7 ng/g), heart (844.7

> ng/g) and the brain (162.9 ng/g) have been reduced by some

> sort of internal " methylation " reconversion of some of the

> inorganic-Hg species into methyl Hg species [kidney (95.9 ng/g),

> liver (71.9 ng/g), heart (89.7 ng/g) and the brain (61.3 ng/g).

>

>Based on the failure to detect any ethyl-Hg species in the heart

>tissues tested, this reviewer thinks that hypothesis " a " is

>probably the valid one.

>

>This seems to be the case because " all " of the " Thimerosal " -

>related, ethyl-Hg species have apparently been reduced to

>mostly inorganic-Hg species (844.7 ng/g) with some remaining

>methyl-Hg species (89.7 ng/g) in the Thimerosal-fed rats'

>heart tissues at 5 days after dosing.

>

>Thus, at this point in time, the methyl-Hg species level in the

>heart (measured as MeHgCl) is roughly 11 % of the inorganic-Hg

>species level (quantitated as mercuric chloride [HgCl2]).

>

>

>A Review of the Blood Data

>

>Returning to the " Results " narrative and focusing only on

>Thimerosal, the authors reported:

> " After the rats were exposed to TM or Met-Hg, both species

>were rapidly absorbed. Figure 1 shows the behavior of mercury

>in the blood of rats exposed to TM … plotted against hours

>after dosing. As can be seen, the blood of rats exposed to

>TM always presented much lower levels of mercury than that

>of Met-Hg-exposed animals. On the other hand, the rate of

>decline in blood mercury was faster in rats exposed to TM.

>Moreover, just 6 h after administration, mercury is found

>mainly as inorganic mercury in TM-exposed animals (data not

>shown). …. After 48 h of mercury administration, most of the

>mercury in the blood of the TM-exposed rat was in the form

>of Ino-Hg with small fractions in the form of Met-Hg and

>Et-Hg. However, 120 h after exposure, neither Et-Hg nor

>Met-Hg was detected in the blood of TM-exposed rats. ….

>Brain concentrations of total Hg were three times lower for

>the TM-exposed animals. Similar levels of Hg in liver were

>found in both Met-Hg- and TM- exposed rats. On the other

>hand, kidney Hg levels were higher for the TM group. Moreover,

>mercury was mainly found as Ino-Hg in liver and kidney,

>corresponding to 83.9 and 95.3% of the total amount in liver

>and kidney tissue, respectively in the TM-exposed group.

>Interestingly, of the total amount of brain mercury in these

>same animals, a significant fraction (23.7%) was found as

>Met-Hg, and 13.5% was in the form of Et-Hg. …. "

>

>Based on the reported data for Thimerosal (including rapid

>absorption and complete conversion in the blood into

>inorganic-Hg species by 120 hours [the time at which the

>test rats were sacrificed]) and the general relation that

> " complete " metabolism of a species can be defined as 6.6

>times the half-life of the species, the half-life of

> " Thimerosal " -related ethyl-Hg species dosed in the blood

>can be estimated as being < 120 hours/6.6 or < 18 hours.

>

>Presuming roughly first-order metabolic kinetics, the peak

>Thimerosal-derived-Hg concentration can be estimated as

>about twice the concentration at 18 hours (about 400 ng of

>Hg/mL based on the data in " Fig. 1 " [Rodriques, page 894])

>or ~ 800 ng of Hg/mL (i.e., roughly 800 ng Hg/g of blood

>presuming the rats' average blood density was about 1 g/mL).

>

>Since the initial Hg dose was 0.5 mg/kg (or 500 ng Hg/g of

>rat weight), clearly, the estimated peak concentration of

>Thimerosal-derived Hg is about 1.6 times what the average

>concentration in the rat would have been, presuming the

>mercury dosed was uniformly distributed.

>

>Given the finding that " just 6 h after administration, mercury "

>[in the rats' blood] " is found mainly as inorganic mercury in

>TM-exposed animals " , it appears that more than half of the

>Thimerosal-derived Hg in the rats blood has already been

>completely metabolized - indicating that the metabolic blood

>half-life for the dosed alkyl Hg species (Thimerosal and its

> " metabolic " breakdown alkyl-Hg-containing components) is

>actually less than 6 hours.

>

>At " 120 h after exposure, neither Et-Hg nor Met-Hg was detected

>in the blood of TM-exposed rats " and the apparent level of

> " inorganic Hg " species probably distributed at different levels

>in the different major components within the blood (simplis-

>tically, the plasma, the red blood cells and the white blood

>cells) is ~ 45 ng per mL (or g) of blood.

>

>Since no evidence is presented that the rats excreted a signi-

>ficant percentage of the initial dose in their urine and/or

>feces in the 5-days after dosing, this reviewer must presume

>(see footnote 6) that probably 85 or more percent of the

>initial dose has left the blood and now resides in the rats'

>tissues in a variety of chemical forms.

>

>

>A Review of the Data for Thimerosal in the Blood and Tissues

>

>Table 1r - omitted in rough text of draft

>

>For the Thimerosal-derived-Hg species (see Table 1r, revised

>from Rodriques " Table 1 " ), this reviewer wishes to make the

>following observations:

> ¨ Unfortunately, the Rodriques study did not provide the

> weights of the rats and the weights of the various organs

> tested so that this reviewer could compute the percentage

> of the applied mercury dose in each of the organs at 5

> days post exposure.

> ¨ The word " identified " in " Table 1 " of the Rodriques article

> should have been replaced with the word " quantified "

> because the sample-work-up procedure used converts the

> mercury present into the discrete " chloride " components

> that are then quantified by comparison of their response

> to the responses observed for various levels of 3 standard

> Hg-containing compounds: mercuric chloride (HgCl2), methyl-Hg

> Chloride (H3CHgCl) and ethyl-Hg chloride (H3C-H2C-HgCl).

> ¨ Based on the initial dosing of the Thimerosal at the level of

> 0.5 mg of Hg/kg of rat body weight, this reviewer notes that,

> after 5 days:

> § The mean level of mercury (Hg) in the brain is more than

> 50% of the administered level of Hg (restated as 500 ng

> Hg per " g " of rat weight, for ease of comparison to the

> tissue levels),

> § The mean level of Hg in the liver is more than 7 times

> the administered level of Hg,

> § The mean level of Hg in the heart is about twice the

> administered level,

> § The mean level of Hg in the kidney is more than 20 times

> the administered level, and

> § The mean level of Hg in the blood is less that 10% of

> the administered level.

> ¨ Presuming the conversion of Thimerosal (and the ethylmercury

> species into which it is converted in the body) into the

> Thimerosal-derived " inorganic mercury " species proceeds by a

> successive demethylation mechanism of some sort, then, in the

> heart, the " ethyl " to " methyl " conversion step has exhausted

> its " ethyl " -Hg substrates.

> ¨ Since the researchers report that there are no ethyl- or

> methyl- Hg species in the Thimerosal-treated rats blood after

> 5 days and, relative to the concentration administered, there

> are measureable levels of ethyl- and/or methyl- mercury species

> in the organs tested, especially in the Thimerosal-treated rats'

> liver and the kidneys, these alkyl-Hg species would seem to be

> strongly bound in these tissues and, therefore, may differ

> chemically from the Thimerosal-derived-Hg species force fed

> to the rats initially.

>

>Thus, this paper clearly establishes that Thimerosal-derived Hg

>preferentially bioaccumulates in various tissues where, in " normal "

>humans (based on other studies), its half-life is, depending on

>the tissue of interest, about one to two decades (10 to 20 years).

>

>However, though the analysis method used in Rodriques permits the

>direct quantification of the mercury present in the blood and

>tissues as " inorganic mercury " (probably mercuric chloride),

> " methylmercury chloride " and " ethylmercury chloride " , it does

>not identify the exact chemical nature of the mercury components

>in the tissue before the work-up used is initiated.

>

>Further, the comparative values it reports relative to some standard

>levels do not necessarily mean that all of the mercury reported as

>a given mercury component (for example, " methymercury " ) was a single

>mercury species of some type before the sample was worked up for

>analysis.

>

>In addition, based on studies using radiolabeled (203Hg) compounds,

>Japanese researchers have shown that, as compared to monkeys, the

>rat is much more resistant to bioaccumulation of mercury in its

>brain than the monkey.

>

>From the radiographs of longitudinal cross sections of the rats that

>this reviewer has observed, the relative distribution of " organic

>mercury " in the monkey, which is presumed to be similar to the

>distribution of mercury in humans, is more uniform across the

>body and accumulates more rapidly and to a greater degree in the

>brain than it does in the rat.

>

>Based on the finding reported in Rodriques, " it appears that the

>toxicokinetics of TM " [Thimerosal] " is completely different from

>that of Met-Hg " [methylmercury chloride], these researchers have

>confirmed that the " toxicokinetics " of these two substances are

>different.

>

>Based on the data disclosed, the Thimerosal-derived mercury species

>were much more rapidly converted into inorganic mercury than the

>methylmercury chloride (MeHgCl) compound studied to assess how well

>its degradation and distribution tracked the results found for

>Thimerosal.

>

>In addition, the significantly higher blood levels of mercury in

>the rats dosed with the MeHgCl points to a less rapid clearance

>of the MeHgCl from the blood, which, based on the tissue data,

>translates into tissue ratio levels for the " inorganic mercury "

>species in the organs studied (brain, liver, heart and kidneys)

>that are, on average, 0.449, 0.172, 0.239 and 0.157 fraction of

>the corresponding levels in the respective mercury species in the

> " Thimerosal " -solution-dosed rats.

>

>For the organic-mercury-containing species, the corresponding

>average MeHgCl-related to Thimerosal-related organic-mercury

>ratios are 7.83, 6.30, 18.0, and 11.9 for the brain, liver, heart

>and kidneys respectively.

>

>Based on these realities, this reviewer must agree, " Met-Hg is

>not an appropriate reference for assessing the risk from exposure

>to TM-derived Hg " .

>

>

>The Thimerosal Toxicokinetic Studies

>

>Clearly, the studies by Burbacher and by Rodriques both support

>the inappropriateness of the study of any compound other than

>Thimerosal when the goal is to understand Thimerosal's

>toxicokinetics.

>

>Hopefully, rather than investing further effort in other such

>comparative studies, these researchers and others will invest

>their experimental time and dollars in studies that directly

>assess the toxicokinetics of Thimerosal at low doses in male

>animals from variety of mammalian models (e.g., the rat, the

>miniature pig, and the monkey).

>

>In these studies, the researchers should inject appropriately

>203Hg-labelled Thimerosal dissolved in a vaccine-like solution

>in a four-armed study encompassing the period from gestation

>until at least half of the animal's nominal lifespan, where:

> v In the first arm, the pattern and mode of administration

> for the injected Thimerosal should conform, in relative

> developmental time, to, and be patterned after, the CDC-

> recommended early childhood vaccination program that

> existed in the USA in 2000 and/or the similar programs

> that exist in the many developing countries today;

> v In the second arm, the pattern and mode of administration

> will be the same as in the first arm except that a true

> placebo (buffered isotonic saline containing sugar and

> sodium thiosalicylate matching the vaccine's amount of

> Thimerosal added) should be administered at each scheduled

> time,

> v In the third arm, the pattern and mode of administration

> for the injected Thimerosal should conform, in relative

> developmental time, to, and be patterned after, the CDC-

> recommended " lifetime " program that existed during the

> period from August 2009 through June 2010 in the USA, and

> v In the fourth arm, the pattern and mode of administration

> will be the same as in the third arm except that a true

> placebo (buffered isotonic saline containing sugar and

> sodium thiosalicylate matching the vaccine's amount of

> Thimerosal) should be administered at each scheduled time.

>

>Hopefully, these " injected Thimerosal in vaccine-like solution "

>studies will, at a minimum, collect blood samples at " 0 " ,

>30 minutes, 1 hr, 4 hours, 12 hours, 24 hours, and, where the

>relative developmental time interval permits, as many additional

>days as needed for the blood level of mercury in the test animals

>to decline to half of its peak level after each dose of mercury

>is administered as well as collect the urine and feces excreted

>each day and appropriately measure the mercury levels and monitor

>the behaviors exhibited by all of the animals.

>

>To assess the nature of the mercury levels in the animals' organs,

>20% of the animals in each arm of the study should be sacrificed

>at 0.25, 0.5, 0.75, 1.0 and 1.5 times the dosing regimen's elapsed

>time.

>

>Then, using the methodology in Rodriques et al., the nature of the

>mercury species in each tissue (at a minimum, in Blood, Kidney,

>Liver, Spleen, Muscle, and Brain) should be assessed along with

>the appropriate counting of the radiolabeled mercury (203Hg) to

>determine non-destructively (or, if that is not feasible,

>destructively) a " true " total Hg level to assess how well the

>total from the speciated analyses matches the total from the

>radiolabeled mercury.

>

>Provided the types of mercury in each of the samples are appro-

>priately separated and assessed, then, in about 1 year for studies

>using the rat to about 3 years when monkeys are used, all of the

>needed data (on mercury levels, mercury excretion patterns, and,

>critically, the behaviors of the developing animals - test and

>control) should be available to address not only the toxicokinetic

>realities but also the types of subacute mercury poisoning symptoms

>that the test animals developed and continued to exhibit until

>they are sacrificed.

>

>In conclusion, instead of doing more less-than-useful comparative

>distribution-within-the-animal studies, researchers should

>undertake the requisite toxicokinetic studies for injected

>Thimerosal in a manner that a) establishes true mass balance,

>B) tracks the nature of the species that are formed and c)

>critically assesses the adverse behavioral effects, if any,

>that appear to develop: 1) after any injection time point, 2)

>persist and worsen over time and 3) exist after the repeated

>injection of Thimerosal according to some pertinent defined

>schedule such as the ones proposed.

>

>Finally, this reviewer would like to thank the Rodriques

>researchers for apparently establishing that the metabolism of

>Thimerosal into the inorganic mercury species that persist in

>the brain probably proceeds through successive demethylation

>stages in which tissue-entrained ethyl mercury species are

>converted into tissue-entrained methylmercury species and the

>tissues-entrained methylmercury species are then converted to

>tissue-entrained inorganic mercury species.

>

>

Please share this message with others who seek

to understand that Thimerosal is an exquisite

mercury posion for mammals including humans.

Thanking everyone in advance for all of your efforts,

no matter how small, to spread this document to the

four corners of the Earth. this reviewer remains ...

Respectfully,

G. King, PhD

http://www.dr-king.com

CoMeD Science Advisor

PS: My apologies if you get more than one email as,

for this email, several lists have been merged

but all the duplicates may not have been removed.

++++++++++++++++++++++++++++++++++++++++++++++++++++

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...